LEVOFLOXACINE, powder, 1g (Sigma 28266-1G-F)

STD SASTAPWDLVX1

Valid Article

Former Code(s): SLASZFR0512
Single use
A single-use device, also referred to as a disposable device, is intended for use on one patient during a single procedure. It is not intended to be reprocessed (i.e., cleaned and disinfected or sterilized).
W0104010699 - Media for mycobacteria cultures - manual & automated (for ast drugs , supplements) - other
European Medical Device Nomenclature (EMDN) is the nomenclature of use by manufacturers when registering their medical devices in the EUDAMED database. EMDN is characterised by its alphanumeric structure that is established in a seven-level hierarchical tree.
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

LEVOFLOXACIN

Reserved for TB culture programmes

Definition

Antimycobacterial used for drug susceptibility testing of M. tuberculosis complex.

Synonym

(-)-Ofloxacin

Specifications

Some restricted information has been hidden. Sign in to see this information

Technical specifications

  • Form: powder
  • Color: faint yellow
  • CAS Number: 100986-85-4
  • Formula: C18H20FN3O4
  • Formula Weight: 361.37 g/mol
  • ​Purity: >=98.0 %

Packaging & Labelling

1 g vial

Instructions for use

  • Always follow the Standard Operations Procedures for the preparation of the stock solution and the working solution.
  • ​The drug working solution is added to the medium during preparation (agar or LJ) or prior to inoculation (MGIT broth tubes).

Storage

  • Keep refrigerated
  • Keep container tightly closed in a dry and well-ventilated place.
  • Avoid formation of dust and aerosols.
  • Light sensitive

Waste management

Substance with biohazardous characteristics. Please contact your watsan referent for advice on proper disposal.

Detailed hazard and precautionary information can be found in the safety data sheet (SDS).

Classification EC Regulation N° 1272/2008

  • Acute toxicity, Oral (Category 4), H302
  • Respiratory sensitization (Category 1), H334
  • Skin sensitization (Category 1), H317
Image Image

Signal Word

Danger

H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled.
P280Wear protective gloves/protective clothing/eye protection/face protection
P285In case of inadequate ventilation wear respiratory protection.
P312Call a POISON CENTER or doctor/physician if you feel unwell.
P301 + P330 + P331IF SWALLOWED: rinse mouth. Do NOT induce vomiting
P302 + P352IF ON SKIN: wash with plenty of soap and water
P304 + P340IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing.
P333 + P313If skin irritation or rash occurs: Get medical advice/attention.

MSF requirements

Reserved for TB culture programmes

Levofloxacin is part of the second line drugs used against M. tuberculosis complex. The test is performed to investigate resistance of the mycobacteria to this antibiotic. ​It can be used for liquid and solid cultures.

Some restricted information has been hidden. Sign in to see this information